Section Arrow
CELU.NASDAQ
- Celularity
(Financial Status)
Quotes are at least 15-min delayed:2026/07/19 17:42 EDT
Regular Hours
Last
 0.7803
+0.0122 (+1.59%)
Day High 
0.8436 
Prev. Close
0.7681 
1-M High
0.8722 
Volume 
16.93K 
Bid
0.7603
Ask
0.7742
Day Low
0.75 
Open
0.76 
1-M Low
0.5601 
Market Cap 
22.23M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.74 
20-SMA 0.71 
50-SMA 0.8 
52-W High 4.35 
52-W Low 0.5601 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.59/-0.42
Enterprise Value
49.13M
Balance Sheet
Book Value Per Share
-1.31
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
26.55M
Operating Revenue Per Share
0.52
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ATAIAtaiBeckley Inc7.22+0.07+0.98%-- 
JSPRJasper Therapeutics0.885+0.111+14.34%-- 
LIMNLiminatus Pharma Inc0.123-0.0247-16.72%-- 
IOVAIovance Biotherapeutics5+0.34+7.30%-- 
RXRXRecursion Pharmaceuticals2.945-0.075-2.48%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.